University Hospital of Cologne
Cologne, Nordrhein-Westfalen, Germany
Michael Hallek received his MD degree from the University of Munich, Germany, in 1985. He trained in pharmacology and internal medicine from 1985 to 1990 at the University and Technical University of Munich. From 1990 to 1992, he spent 2 years as a research associate at the Dana Farber Cancer Institute at Harvard Medical School, Boston, USA. 1992-2003 Further training and several positions at the University of Munich in internal medicine and in hematology and oncology. In 1996, he founded the German CLL Study Group and is its chairman until today. Since 2003 Professor of Medicine, Director and Chair of the Department I of Internal Medicine at the University of Cologne. Since 2007 chairman of the Center for Integrated Oncology (CIO), the joint comprehensive cancer center of the Universities Aachen, Bonn, Cologne and Düsseldorf.
Since 2011 Member of the National Academy of Sciences (Leopoldina). Paul-Martini Award in 2012, the Binet-Rai-Medal in 2013, the Walter-Siegenthaler Medal in gold in 2016, the German Cancer Award 2017, José Carreras Award 2019 of the European Hematology Association, Ham-Wasserman Lecture of the American Society of Hematology in 2018, Henry Kaplan Memorial Lecture of the International Conference on Malignant Lymphoma in 2021. Since 2020, associate editor of the Blood journal. Member Scientific Committee of the Robert Koch Institute and Chair Scientific Committee of the German José Carreras Leukemia Foundation since 2021. Since 2022, Member Science Council of the German Government and Chairperson, Collaborative Research Center 1530 on B cell malignancies.
Disclosure information not submitted.
Friday, October 21, 2022
10:20 AM – 11:55 AM
Friday, October 21, 2022
10:25 AM – 10:45 AM
Friday, October 21, 2022
11:35 AM – 11:55 AM